ELUT Q2 2023 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-49.7% YoY

Gross Profit

$3M42.7% margin

Operating Income

-$6M-99.3% margin

Net Income

-$11M-167.2% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$687,000

Balance Sheet

Total Assets

$52M

Total Liabilities

$74M

Stockholders' Equity

-$22M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$13M	-49.7%
Gross Profit	$3M	$5M	-44.6%
Operating Income	-$6M	-$8M	+22.9%
Net Income	-$11M	-$9M	-13.0%